West Pharmaceutical Services Inc. has authorized a new share repurchase program for up to $1 billion of the company's common stock. The timing and number of shares to be repurchased will depend on various factors, and the program has no expiration date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. West Pharmaceutical Services Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202602171600PR_NEWS_USPR_____NE89779) on February 17, 2026, and is solely responsible for the information contained therein.